The Methodological Quality Assessment of Systematic Reviews/meta-analyses of Chronic Prostatitis/chronic Pelvic Pain Syndrome Using AMSTAR2

Overview

Journal BMC Med Res Methodol

Publisher Biomed Central

Specialties General Medicine
Health Services

Date 2023 Nov 27

PMID 38012566

Authors

Xin Guan

Yongfeng Lao

Jian Wang

Yanan Wang

Yanan Bai

Xiaolong Li

Shuai Liu

ZeWen Li

Fuhan Li

Zhilong Dong

Affiliations

Soon will be listed here.

Abstract

Background: This study aimed to assess the methodological quality of the systematic reviews/meta-analyses (SRs/MAs) of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) using A Measurement Tool to Assess systematic Reviews (AMSTAR2) and to explore the potential influencing factors.

Methods: PubMed, EMBASE and Cochrane Library databases were searched for relevant studies. AMSTAR2 was used for evaluating the methodological quality of eligible SRs/MAs. Differences between methodological characteristics of SRs/MAs were compared using chi-square tests. The intra-class correlation coefficient (ICC) was used to assess reviewer agreement in the pre-experiment. Multivariate regression analysis was used to identify potential factors affecting methodological quality.

Results: A total of 45 SRs/MAs were included. After AMSTAR2 evaluation, only two (4.4%) of 45 SRs/MAs were moderate, three (6.7%) were rated as low quality, and the remainder 40 (88.9%) were rated as critically low quality. Among the 16 items of AMSTAR2, item 3 and item 10 had the poorest adherence. Item 4 received the most significant number of "Partial Yes" responses. Univariable analysis indicated that there were significant differences in methodological quality in SRs between different continents (P = 0.027) as well as between preregistered SRs and those that were not (P = 0.004). However, in multivariate analysis, there was no significant association between methodological quality and the following research characteristics: publication year, continent, whether reporting followed Preferred Reporting Items for Systematic Reviews (PRISMA), preregistration, funding support, randomized controlled trials (RCT) enrollment, whether SR was published in the Cochrane Database of Systematic Reviews (CDSR), and whether with meta-analysis. Additionally, subgroup analysis based on interventional SRs/MAs showed that continent was independently associated with the methodological quality of SRs/MAs of CP/CPPS via univariable and multivariate analysis.

Conclusions: Our study demonstrates that the methodological quality of SRs/MAs of CP/CPPS was generally poor. SRs/MAs of CP/CPPS should adopt the AMSTAR2 to enhance their methodological quality.

Citing Articles

Characteristics and quality of systematic reviews led by Peruvian authors: A scoping review.

Branez-Condorena A, Soriano-Moreno D, Mejia J, Chavez-Rimache L, Fernandez-Guzman D, Martinez-Rivera R Heliyon. 2024; 10(17):e36887.

PMID: 39286140 PMC: 11403479. DOI: 10.1016/j.heliyon.2024.e36887.

References

Birowo P, Rangganata E, Rasyid N, Atmoko W . Efficacy and safety of extracorporeal shockwave therapy for the treatment of chronic non-bacterial prostatitis: A systematic review and meta-analysis. PLoS One. 2020; 15(12):e0244295. PMC: 7769278. DOI: 10.1371/journal.pone.0244295. View

Lao Y, He L, Zhang P, Dong Z . Efficacy and safety of selective serotonin re-uptake inhibitors for chronic prostatitis/chronic pelvic pain syndrome: A systematic review and network meta-analysis. Asian J Surg. 2022; 45(12):2810-2812. DOI: 10.1016/j.asjsur.2022.06.047. View

Liu B, Wang Y, Chen S . Effect of acupuncture on clinical symptoms and laboratory indicators for chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis. Int Urol Nephrol. 2016; 48(12):1977-1991. DOI: 10.1007/s11255-016-1403-z. View

Cai T, Verze P, Rocca R, Anceschi U, De Nunzio C, Mirone V . The role of flower pollen extract in managing patients affected by chronic prostatitis/chronic pelvic pain syndrome: a comprehensive analysis of all published clinical trials. BMC Urol. 2017; 17(1):32. PMC: 5401347. DOI: 10.1186/s12894-017-0223-5. View

Shea B, Reeves B, Wells G, Thuku M, Hamel C, Moran J . AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017; 358:j4008. PMC: 5833365. DOI: 10.1136/bmj.j4008. View

Qin Z, Wu J, Zhou J, Liu Z . Systematic Review of Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Medicine (Baltimore). 2016; 95(11):e3095. PMC: 4839929. DOI: 10.1097/MD.0000000000003095. View

Qin Z, Wu J, Xu C, Liu Z . Using meta-regression approach to explore the dose-response association between acupuncture sessions and acupuncture effects on chronic prostatitis/chronic pelvic pain syndrome. Ann Transl Med. 2019; 7(6):116. PMC: 6465436. DOI: 10.21037/atm.2018.11.45. View

Page M, Moher D, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021; 372:n160. PMC: 8005925. DOI: 10.1136/bmj.n160. View

Zhao Y, Lin J, Dong Y, Tian Z, Ye Y, Ma Z . Neuroimaging Studies of Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Pain Res Manag. 2022; 2022:9448620. PMC: 9095382. DOI: 10.1155/2022/9448620. View

10.

Sun S, Zhao L, Zhou X, Liu X, Xie Z, Ren J . Methodological, reporting, and evidence quality of systematic reviews of traditional Chinese medicine for ischemic stroke. Front Pharmacol. 2023; 14:1047650. PMC: 9947652. DOI: 10.3389/fphar.2023.1047650. View

11.

Useem J, Brennan A, LaValley M, Vickery M, Ameli O, Reinen N . Systematic Differences between Cochrane and Non-Cochrane Meta-Analyses on the Same Topic: A Matched Pair Analysis. PLoS One. 2015; 10(12):e0144980. PMC: 4686011. DOI: 10.1371/journal.pone.0144980. View

12.

Anothaisintawee T, Attia J, Nickel J, Thammakraisorn S, Numthavaj P, McEvoy M . Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA. 2011; 305(1):78-86. DOI: 10.1001/jama.2010.1913. View

13.

Chartres N, Fabbri A, Bero L . Association of Industry Sponsorship With Outcomes of Nutrition Studies: A Systematic Review and Meta-analysis. JAMA Intern Med. 2016; 176(12):1769-1777. DOI: 10.1001/jamainternmed.2016.6721. View

14.

Horwitz R, Hayes-Conroy A, Caricchio R, Singer B . From Evidence Based Medicine to Medicine Based Evidence. Am J Med. 2017; 130(11):1246-1250. DOI: 10.1016/j.amjmed.2017.06.012. View

15.

Hammel C, Pandis N, Pieper D, Faggion Jr C . Methodological assessment of systematic reviews of in-vitro dental studies. BMC Med Res Methodol. 2022; 22(1):110. PMC: 9006561. DOI: 10.1186/s12874-022-01575-z. View

16.

La Torre G, Bova R, Cocchiara R, Sestili C, Tagliaferri A, Maggiacomo S . What Are the Determinants of the Quality of Systematic Reviews in the International Journals of Occupational Medicine? A Methodological Study Review of Published Literature. Int J Environ Res Public Health. 2023; 20(2). PMC: 9862101. DOI: 10.3390/ijerph20021644. View

17.

Qin Z, Zhang C, Guo J, Kwong J, Li X, Pang R . Oral pharmacological treatments for chronic prostatitis/chronic pelvic pain syndrome: A systematic review and network meta-analysis of randomised controlled trials. EClinicalMedicine. 2022; 48:101457. PMC: 9125656. DOI: 10.1016/j.eclinm.2022.101457. View

18.

Lok W, Lin T, Cao D, Wei Q . Is Serenoa repens effective for the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)? A systematic review and meta-analysis. Asian J Surg. 2022; 45(9):1746-1747. DOI: 10.1016/j.asjsur.2022.01.038. View

19.

Yan P, Yao L, Li H, Zhang M, Xun Y, Li M . The methodological quality of robotic surgical meta-analyses needed to be improved: a cross-sectional study. J Clin Epidemiol. 2018; 109:20-29. DOI: 10.1016/j.jclinepi.2018.12.013. View

20.

Zhang Y, Ma H, Nan T, Li Y, Zheng W, Zhou Z . Comparative Efficacy of Oral Chinese Patent Medicine for Chronic Prostatitis/Chronic Pelvic Pain Syndrome With Sexual Dysfunction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials. Front Pharmacol. 2021; 12:649470. PMC: 8143435. DOI: 10.3389/fphar.2021.649470. View